SPARC and hepatocellular carcinoma: To this end, we quantified the levels of serum SPARC and analyzed their correlation to prognosis in patients with HCC after TACE, as well as performed immunohistochemical assays to evaluate the expression of SPARC in different grades of pathological tissues.